Immunophage is a clinical-stage biotech company focusing on discovering, developing, and commercializing innovative drugs globally for patients worldwide. The company strengthens its R&D pipeline by continually exploring novel disease pathophysiology, refining new targets, and discovering small-molecule or large-molecule drugs. Immunophage aims to advance two innovative programs into clinical trials by combining internal R&D expertise and partnerships with global biopharmaceutical companies.
View More
Immunophage is a clinical-stage biopharmaceutical company
focused on developing next-generation immunotherapies to benefit
patients worldwide.
View More
Cpyright © 2023 Nanjing Immunophage Biotech Co.,Ltd
All Rights Reserved. 苏ICP备2022026466号-1 苏公网安备 32011202000830号